Chat with us
Research Assistance
Online
  • Please enter your first name.

North America Artificial Organs And Bionics Market

The artificial organs and bionics market in North America is expected to reach a projected revenue of US$ 29,415.6 million by 2030. A compound annual growth rate of 8.4% is expected of North America artificial organs and bionics market from 2023 to 2030.

  • MedTech
    • General Surgery
      • artificial organ and bionics
Revenue, 2022 (US$M)
$15,433.3
Forecast, 2030 (US$M)
$29,415.6
CAGR, 2023 - 2030
8.4%
Report Coverage
North America

North America Artificial Organs And Bionics Market, 2018-2030 (US$M)

North America Artificial Organs And Bionics Market, 2018-2030 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the artificial organ and bionics market

Every figure cited from GVR research

North America artificial organs and bionics market highlights

  • The North America artificial organs and bionics market generated a revenue of USD 15,433.3 million in 2022.
  • The market is expected to grow at a CAGR of 8.4% from 2023 to 2030.
  • In terms of segment, artificial organ was the largest revenue generating product in 2022.
  • Artificial bionics is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.


North America data book summary

Market revenue in 2022USD 15,433.3 million
Market revenue in 2030USD 29,415.6 million
Growth rate8.4% (CAGR from 2022 to 2030)
Largest segmentArtificial organ
Fastest growing segmentArtificial bionics
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationArtificial Organ, Artificial bionics
Key market players worldwideZimmer Biomet Holdings Inc, Boston Scientific Corp, Cochlear Ltd, Edwards Lifesciences Corp, Ekso Bionics Holdings Inc, Medtronic PLC, Symbotic Inc Ordinary Shares - Class A, Johnson & Johnson, Berlin Heart GmbH, SynCardia Systems


Other key industry trends

  • In terms of revenue, North America region accounted for 45.0% of the global artificial organs and bionics market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 16,916.9 million by 2030.

North America accounted for the largest share of the artificial organ and bionics market, owing to an increase in the number of organ transplantation procedures and growth in the need for organ transplants due to high incidence of organ failures.

According to the Organ Procurement and Transplantation Network, 118,020 individuals required organ transplantation in the U.S in 2017. With an increasing prevalence of chronic diseases such as cancer, kidney diseases, and cardiac disorders, the incidence of organ failure has also increased. This has led to a high demand for artificial organs, which has further encouraged R&D in this field.

An increase in the number of chronic kidney diseases in the region is likely to boost the demand for artificial organs in the region. Thus, North America’s artificial organ and bionics market is expected to grow at a lucrative rate over the forecast period.

No credit card required*

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Artificial Organ And Bionics Companies

NameProfile# EmployeesHQWebsite
Johnson & JohnsonView profile 134,400One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933www.jnj.com
Medtronic PLCView profile 95,000Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2www.medtronic.com
Boston Scientific CorpView profile 48,000300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234www.bostonscientific.com
Zimmer Biomet Holdings IncView profile 18,000345 East Main Street, Warsaw, IN, United States, 46580www.zimmerbiomet.com
Ekso Bionics Holdings IncView profile 72101 Glacier Point, Suite A, San Rafael, CA, United States, 94901www.eksobionics.com
Cochlear LtdView profile 4,7731 University Avenue, Macquarie University, Sydney, NSW, Australia, 2109www.cochlear.com
Edwards Lifesciences CorpView profile 19,800One Edwards Way, Irvine, CA, United States, 92614www.edwards.com
Symbotic Inc Ordinary Shares - Class AView profile 1,300200 Research Drive, Wilmington, MA, United States, 01887www.symbotic.com
Berlin Heart GmbHView profile 501-1000Berlin, Berlin, Germany, Europewww.berlinheart.de/
SynCardia SystemsView profile 101-250Tucson, Arizona, United States, North Americawww.syncardia.com/

North America artificial organ and bionics

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Artificial Organs And Bionics Market will help companies and investors design strategic landscapes.


Artificial Organ was the largest segment with a revenue share of 70.31% in 2022.

Horizon Databook has segmented the North America artificial organs and bionics market based on artificial organ, artificial bionics covering the revenue growth of each sub-segment from 2018 to 2030.




North America accounted for the largest share of the artificial organ and bionics market, owing to an increase in the number of organ transplantation procedures and growth in the need for organ transplants due to high incidence of organ failures.

According to the Organ Procurement and Transplantation Network, 118,020 individuals required organ transplantation in the U.S in 2017. With an increasing prevalence of chronic diseases such as cancer, kidney diseases, and cardiac disorders, the incidence of organ failure has also increased. This has led to a high demand for artificial organs, which has further encouraged R&D in this field.

An increase in the number of chronic kidney diseases in the region is likely to boost the demand for artificial organs in the region. Thus, North America’s artificial organ and bionics market is expected to grow at a lucrative rate over the forecast period.

  • North America Artificial Organs And Bionics Market Product Outlook (Revenue, USD Million , 2018-2030)
    • Artificial Organ
    • Artificial bionics
  • North America Artificial Organs And Bionics Market Technology Outlook (Revenue, USD Million , 2018-2030)
    • Mechanical
    • Electronic

Reasons to subscribe to artificial organ and bionics databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of artificial organ and bionics databook

  • Our clientele includes a mix of artificial organ and bionics companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America artificial organ and bionics, including forecasts for subscribers. This continent databook contains high-level insights into North America artificial organ and bionics from 2018 to 2030, including revenue numbers, major trends, and company profiles.

North America Artificial Organs And Bionics Market, 2018-2030 (US$M)

No Access Stack Chart

North America artificial organs and bionics market statistics, by product, 2018-2030 (US$M)

No Access Pie Chart

North America artificial organs and bionics market statistics, by country, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more